Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Exelixis Inc. (EXEL)

19.77   -0.74 (-3.61%) 05-23 16:00
Open: 20.14 Pre. Close: 20.43
High: 20.615 Low: 19.46
Volume: 2,563,129 Market Cap: 5966M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 20.322 - 20.425 20.425 - 20.505
Low: 19.223 - 19.33 19.33 - 19.412
Close: 19.6 - 19.78 19.78 - 19.918

Technical analysis

as of: 2019-05-23 4:25:02 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 23.95     One year: 25.18
Support: Support1: 18.80    Support2: 15.64
Resistance: Resistance1: 20.51    Resistance2: 21.56
Pivot: 19.89
Moving Average: MA(5): 19.93     MA(20): 19.90
MA(100): 22.21     MA(250): 20.23
MACD: MACD(12,26): -0.51     Signal(9): -0.69
Stochastic oscillator: %K(14,3): 67.77     %D(3): 59.91
RSI: RSI(14): 43.74
52-week: High: 25.31  Low: 13.42  Change(%): -3.6
Average Vol(K): 3-Month: 324209  10-Days: 292316

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
EXEL has closed above bottom band by 44.8%. Bollinger Bands are 37.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 22 May 2019 16:14:54 Z
Merck to Buy Private Cancer Drugmaker Peloton Therapeutics

Tue, 21 May 2019 17:06:55 Z
EXEL Crosses Above Key Moving Average Level

Wed, 15 May 2019 15:14:12 Z
Pfizer's Bavencio+Inlyta Combo Gets FDA Nod for Kidney Cancer

Tue, 14 May 2019 13:08:10 Z
These 3 Value Stocks Are Absurdly Cheap Right Now

Tue, 07 May 2019 14:11:32 Z
Where Will Gilead Sciences Spend Its Cash?

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 301.77
Shares Float (M) 297.53
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS 1.430
EPS Est. Current Year 0.280
EPS Est. Next Year 0.670
EPS Est. Next Quarter 0.090
Forward EPS 1.280
Book Value (p.s.) 4.310
PEG Ratio 0.45
Profit Margin 75.97
Operating Margin 47.73
Return on Assets (ttm) 56.1
Return on Equity (ttm) 63.3
Qtrly Rev. Growth 0.8
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth -34.60
Operating Cash Flow (M) 505.50
Levered Free Cash Flow (M) 304.75

Stock Valuations

P/E 13.83
P/E Growth Ratio -0.04
P/BV 4.59
P/S 2086011392.00
P/CF 11.80

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.